Elham Rismani

441 total citations
37 papers, 327 citations indexed

About

Elham Rismani is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Elham Rismani has authored 37 papers receiving a total of 327 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 11 papers in Immunology and 5 papers in Oncology. Recurrent topics in Elham Rismani's work include Monoclonal and Polyclonal Antibodies Research (4 papers), Toxin Mechanisms and Immunotoxins (3 papers) and Cancer Cells and Metastasis (3 papers). Elham Rismani is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (4 papers), Toxin Mechanisms and Immunotoxins (3 papers) and Cancer Cells and Metastasis (3 papers). Elham Rismani collaborates with scholars based in Iran, Sweden and United States. Elham Rismani's co-authors include Behrooz Johari, Mehdi Kadivar, Ali Sharafi, Mahmoud Gharbavi, Ladan Mafakher, Ladan Teimoori‐Toolabi, Yousef Mortazavi, Navid Mousazadeh, Hamzeh Rahimi and Amir Hossein Taromchi and has published in prestigious journals such as Scientific Reports, Frontiers in Immunology and Archives of Biochemistry and Biophysics.

In The Last Decade

Elham Rismani

30 papers receiving 323 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Elham Rismani Iran 12 194 62 51 46 38 37 327
Neda Rostami Iran 12 172 0.9× 73 1.2× 59 1.2× 38 0.8× 28 0.7× 21 346
Edward Cedrone United States 15 336 1.7× 60 1.0× 50 1.0× 46 1.0× 111 2.9× 37 551
Sibei Lei China 10 203 1.0× 41 0.7× 70 1.4× 61 1.3× 93 2.4× 14 342
Zhenlin Ouyang China 13 214 1.1× 20 0.3× 27 0.5× 47 1.0× 39 1.0× 26 346
Pooja Manchanda India 9 154 0.8× 45 0.7× 44 0.9× 63 1.4× 56 1.5× 50 435
Farnaz Khodabakhsh Iran 10 179 0.9× 31 0.5× 34 0.7× 42 0.9× 42 1.1× 19 306
Degui Lin China 13 239 1.2× 85 1.4× 50 1.0× 101 2.2× 57 1.5× 25 538
Shiqin Li China 9 252 1.3× 52 0.8× 61 1.2× 56 1.2× 45 1.2× 16 387
Shweta Pandey India 11 239 1.2× 36 0.6× 36 0.7× 50 1.1× 42 1.1× 22 476

Countries citing papers authored by Elham Rismani

Since Specialization
Citations

This map shows the geographic impact of Elham Rismani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elham Rismani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elham Rismani more than expected).

Fields of papers citing papers by Elham Rismani

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elham Rismani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elham Rismani. The network helps show where Elham Rismani may publish in the future.

Co-authorship network of co-authors of Elham Rismani

This figure shows the co-authorship network connecting the top 25 collaborators of Elham Rismani. A scholar is included among the top collaborators of Elham Rismani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elham Rismani. Elham Rismani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Widowati, Wahyu, et al.. (2025). M2 macrophages-based immunotherapy: A new therapeutic approach in liver fibrosis. Advanced Pharmaceutical Bulletin. 15(2). 314–325.
2.
3.
Rismani, Elham, et al.. (2025). Targeting CD84 protein on myeloid-derived suppressor cells as a novel immunotherapy in solid tumors. Computer Methods and Programs in Biomedicine. 261. 108607–108607.
4.
Rismani, Elham, et al.. (2024). Structure-based evaluation of the envelope domain III–nonstructural protein 1 (EDIII-NS1) fusion as a dengue virus vaccine candidate. Journal of Biomolecular Structure and Dynamics. 43(12). 6026–6044. 3 indexed citations
5.
Zainodini, Nahid, Maryam Abolhasani, Monireh Mohsenzadegan, Mohammad M. Farajollahi, & Elham Rismani. (2024). Overexpression of Transmembrane Phosphatase with Tensin homology (TPTE) in prostate cancer is clinically significant, suggesting its potential as a valuable biomarker. Journal of Cancer Research and Clinical Oncology. 150(3). 165–165. 2 indexed citations
6.
Mafakher, Ladan, Elham Rismani, Mina Saeedi, et al.. (2023). Investigation of biological activities of two cultivars of Cicer arietinum proteins mass associated with A lzheimer's disease. Proteins Structure Function and Bioinformatics. 91(7). 859–871. 2 indexed citations
7.
8.
9.
10.
Gharbavi, Mahmoud, et al.. (2023). Targeted anti-tumor synergistic effects of Myc decoy oligodeoxynucleotides-loaded selenium nanostructure combined with chemoradiotherapy on LNCaP prostate cancer cells. Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics. 32(1). 101–125. 15 indexed citations
11.
Rismani, Elham, Jahan B. Ghasemi, Mohammad Shabani, et al.. (2023). Design of ion channel blocking, toxin-like Kunitz inhibitor peptides from the tapeworm, Echinococcus granulosus, with potential anti-cancer activity. Scientific Reports. 13(1). 11465–11465. 3 indexed citations
12.
Rismani, Elham, et al.. (2022). In silico design of fusion keratinocyte growth factor containing collagen-binding domain for tissue engineering application. Journal of Molecular Graphics and Modelling. 118. 108351–108351. 6 indexed citations
13.
Mirtavoos‐Mahyari, Hanifeh, et al.. (2021). Primary Erlotinib Resistance in a Patient with Non-Small Cell Lung Cancer Carrying Simultaneous Compound EGFR L718A, Q849H, and L858R Mutations. BioMolecular Concepts. 12(1). 164–174. 2 indexed citations
14.
Mafakher, Ladan, et al.. (2021). Structure-based study of immune receptors as eligible binding targets of coronavirus SARS-CoV-2 spike protein. Journal of Molecular Graphics and Modelling. 108. 107997–107997. 7 indexed citations
15.
16.
17.
Gharbavi, Mahmoud, Behrooz Johari, Elham Rismani, et al.. (2020). NANOG Decoy Oligodeoxynucleotide–Encapsulated Niosomes Nanocarriers: A Promising Approach to Suppress the Metastatic Properties of U87 Human Glioblastoma Multiforme Cells. ACS Chemical Neuroscience. 11(24). 4499–4515. 34 indexed citations
18.
19.
20.
Dinarvand, Rassoul, et al.. (2018). Preparation and investigation of indirubin‐loaded SLN nanoparticles and their anti‐cancer effects on human glioblastoma U87MG cells. Cell Biology International. 43(1). 2–11. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Neda Rostami Breakdown of academic impact, for papers by Edward Cedrone Breakdown of academic impact, for papers by Sibei Lei Breakdown of academic impact, for papers by Zhenlin Ouyang Breakdown of academic impact, for papers by Pooja Manchanda Breakdown of academic impact, for papers by Farnaz Khodabakhsh Breakdown of academic impact, for papers by Degui Lin Breakdown of academic impact, for papers by Shiqin Li Breakdown of academic impact, for papers by Shweta Pandey
Rankless by CCL
2026